pyrroles has been researched along with Foot Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berneburg, M; Guenova, E; Hoetzenecker, W; Metzler, G; Mitev, V; Röcken, M; Voykov, B; Weber, HO | 1 |
| Bukowski, RM | 1 |
| Chu, D; Lacouture, ME; Weiner, E; Wu, S | 1 |
1 review(s) available for pyrroles and Foot Diseases
| Article | Year |
|---|---|
Risk of hand-foot skin reaction with the multitargeted kinase inhibitor sunitinib in patients with renal cell and non-renal cell carcinoma: a meta-analysis.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Drug Eruptions; Foot Diseases; Hand Dermatoses; Humans; Incidence; Indoles; Kidney Neoplasms; Paresthesia; Protein Kinase Inhibitors; Pyrroles; Risk Factors; Sunitinib | 2009 |
2 other study(ies) available for pyrroles and Foot Diseases
| Article | Year |
|---|---|
Palmar-plantar erythrodysesthesia secondary to sunitinib treatment resulting in necrotic foot syndrome aggravated by background diabetic vascular disease.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Renal Cell; Diabetic Angiopathies; Drug Eruptions; Foot; Foot Diseases; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Necrosis; Paresthesia; Pyrroles; Skin; Sunitinib | 2008 |
Tyrosine kinase inhibitors in advanced renal cell carcinoma: the evolving treatment paradigm.
Topics: Benzenesulfonates; Carcinoma, Renal Cell; Drug Eruptions; Foot Diseases; Hand Dermatoses; Humans; Indoles; Kidney Neoplasms; Niacinamide; Paresthesia; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrroles; Sorafenib; Sunitinib | 2009 |